Thirty-day mortality in ED patients with new onset atrial fibrillation and actively treated cancer

2015/07/21 by Thomas Lardaro, Wesley H. Self, Tyler W. Barrett
Medicine · #Atrial Fibrillation Management and Outcomes #Atrial fibrillation #Cancer #Cardiology #Chemotherapy-induced cardiotoxicity and mitigation #Intensive care medicine #Internal medicine #Medicine #Venous Thromboembolism Diagnosis and Management

paper · doi:10.1016/j.ajem.2015.07.033

openalex publication_date 2015/07/21 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Citations

• Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
• Heart Disease and Stroke Statistics—2014 Update
• Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients
• Prevalence of Diagnosed Atrial Fibrillation in Adults
• Lifetime Risk for Development of Atrial Fibrillation